4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Wellgistics Health Inc (WGRX) operates in the Medical Distribution industry and is headquartered in Tampa, United States. Its market capitalization is roughly $183 million. In the fiscal year ended 2025-12-31, WGRX reported $23M in revenue and ($101M) in net income.
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products.
Interactive charts & full statements → Open the WGRX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $23M | $18M | $0M | $33M |
| Gross Profit | ($6M) | $2M | $0M | $6M |
| Operating Income (EBIT) | ($81M) | ($6M) | ($3M) | ($3M) |
| Net Income | ($101M) | ($7M) | ($3M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $2M | $3M | $8M | $11M |
| Gross Profit | $0M | ($8M) | $0M | $0M | $1M |
| Operating Income (EBIT) | ($6M) | ($13M) | ($32M) | ($6M) | ($31M) |
| Net Income | ($8M) | ($28M) | ($34M) | ($7M) | ($32M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $30M | $57M | $0M | $0M |
| Total Liabilities | $43M | $51M | $3M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WGRX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms